Stockholders' Equity (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jan. 06, 2015 |
Jul. 31, 2015 |
Jan. 31, 2015 |
Sep. 30, 2015 |
Sep. 30, 2014 |
Sep. 30, 2015 |
Sep. 30, 2014 |
Dec. 31, 2014 |
|||
| Stockholders' Equity (Textual) | ||||||||||
| Common stock, authorized | 75,000,000 | 75,000,000 | 75,000,000 | |||||||
| Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
| Preferred stock, authorized | 5,000,000 | 5,000,000 | 5,000,000 | |||||||
| Preferred stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
| Stock-based compensation | $ 94,389 | $ 17,262 | $ 310,594 | $ 239,760 | ||||||
| Stock options | 3,659,083 | 3,659,083 | ||||||||
| Proceeds from exercise of Agent options | $ 55,548 | |||||||||
| Recognized options vest over period | 4 years | |||||||||
| Exercise Price 1.00 [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Option granted exercise price | $ 1.00 | $ 1.00 | ||||||||
| Stock options | [1] | 1,049,272 | 1,049,272 | |||||||
| 2011 Plan [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Equity incetive plan, description | In accordance with the rules of the TSX Venture Exchange regarding equity incentive plans, the number of shares that can be reserved for issuance under the 2011 Plan is equal to 20% of the Companys common stock outstanding at the completion of the offering. | |||||||||
| Common stock for future issuance | 6,453,069 | 3,525,134 | 3,525,134 | |||||||
| Stock Options [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Number of options granted | 1,104,820 | |||||||||
| Weighted average exercise price | $ 1.00 | |||||||||
| Weighted average fair value | $ 0.38 | |||||||||
| Agent options exercised | (55,548) | |||||||||
| Option issued to employees and consultants exercisable, shares | 1,584,567 | 1,584,567 | 459,437 | |||||||
| Weighted average exercisable price | $ 0.32 | $ 0.32 | $ 0.17 | |||||||
| Stock Options [Member] | Employees And Consultants [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Number of options granted | 318,124 | |||||||||
| Weighted average exercise price | $ 1.00 | |||||||||
| Option issued to employees and consultants exercisable, shares | 318,124 | |||||||||
| Weighted average exercisable price | $ 1.00 | |||||||||
| Recognized options vest over period | 4 years | |||||||||
| Aggregate grant fair value | $ 233,550 | |||||||||
| Compensation Options [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Option granted exercise price | $ 1.00 | |||||||||
| Number of options granted to agents | 786,696 | |||||||||
| Agent options exercised | 55,548 | |||||||||
| Proceeds from exercise of Agent options | $ 55,548 | |||||||||
| Warrants outstanding, description | The Compensation Options expire on July 6, 2016. Each whole warrant issuable upon exercise of Compensation Options is exercisable to acquire one share of common stock at an exercise price of $2.00 per share at any time up to January 6, 2017, subject to the Company's right to accelerate the expiration time of the warrants if at any time the volume-weighted average trading price of its common stock is equal to or exceeds $3.00 per share for twenty (20) consecutive trading days. | |||||||||
| Warrant exercise price per share | $ 2.00 | |||||||||
| Common Stock [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Conversion of of Series B Preferred into common stock | 5,400,000 | |||||||||
| Warrant [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Warrants issued to purchase of common stock | 7,002,774 | 7,002,774 | ||||||||
| Warrants outstanding, description | The warrants are exercisable through January 6, 2017 at a price of $2.00 per share. The warrants are subject to the Company's right to accelerate the expiration time of the warrants if at any time the volume-weighted average trading price of its common stock is equal to or exceeds $3.00 per share for twenty (20) consecutive trading days. | |||||||||
| Warrant weighted average exercise price | $ 1.80 | $ 1.80 | ||||||||
| Weighted average remaining contractual life, warrant | 2 years 18 days | |||||||||
| Aggregate intrinsic value, warrant | $ 814,507 | $ 814,507 | ||||||||
| Warrants outstanding and exercisable to purchase | 7,936,391 | 7,936,391 | ||||||||
| Amendment [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Authorized to issue and sale, shares | 80,000,000 | |||||||||
| Common stock, authorized | 75,000,000 | |||||||||
| Common stock, par value | $ 0.001 | |||||||||
| Preferred stock, authorized | 5,000,000 | |||||||||
| Preferred stock, par value | $ 0.001 | |||||||||
| IPO and Private Placement [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Warrants issued to purchase of common stock | 6,975,000 | |||||||||
| Number of shares sold | 13,950,000 | |||||||||
| Proceeds from sale of shares | $ 13,950,000 | |||||||||
| Warrants outstanding, description | Each whole warrant is exercisable to acquire one share of the Company's common stock at a price of $2.00 per share at any time up to January 6, 2017, subject to the Company's right to accelerate the expiration time of the warrants if at any time the volume-weighted average trading price of its common stock is equal to or exceeds $3.00 per share for twenty (20) consecutive trading days. | |||||||||
| Proceeds from issuance, net | $ 12,953,484 | |||||||||
| IPO [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Price per sale of unit | $ 1.00 | |||||||||
| Number of units sold | 11,250,000 | |||||||||
| Proceeds from sale of units | $ 11,250,000 | |||||||||
| Number of options granted to agents | 786,696 | |||||||||
| IPO [Member] | Stock Options [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Number of options granted | 127,532 | |||||||||
| Weighted average exercise price | $ 0.26 | |||||||||
| Weighted average fair value | $ 0.87 | |||||||||
| Share-based expense | $ 53,037 | |||||||||
| IPO [Member] | Compensation Options [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Number of options granted to agents | 731,148 | |||||||||
| Private Placement [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Price per sale of unit | $ 1.00 | |||||||||
| Number of units sold | 2,700,000 | |||||||||
| Proceeds from sale of units | $ 2,700,000 | |||||||||
| Series B Preferred Stock [Member] | ||||||||||
| Stockholders' Equity (Textual) | ||||||||||
| Conversion of of Series B Preferred into common stock | 5,400,000 | |||||||||
| ||||||||||